The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, cilt.26, sa.1, ss.51-57, 2011 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 26 Sayı: 1
- Basım Tarihi: 2011
- Doi Numarası: 10.1002/hup.1169
- Dergi Adı: HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.51-57
- Van Yüzüncü Yıl Üniversitesi Adresli: Evet
Özet
Objective To investigate the comparative efficacy of aripiprazole and risperidone as augmenting agents in the treatment of obsessive-compulsive disorder (OCD) patients who did not show a >= 35% decrease in the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) after 12-week monotherapy with selective serotonin reuptake inhibitors (SSRIs).